Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Culturally Adapting CBT for East Asian Youth in Ontario

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03711344
Recruitment Status : Unknown
Verified January 2019 by Centre for Addiction and Mental Health.
Recruitment status was:  Recruiting
First Posted : October 18, 2018
Last Update Posted : February 1, 2019
Sponsor:
Collaborators:
East Metro Youth Services
Hong Fook Mental Health Association
Ontario Centre of Excellence for Child and Youth Mental Health
Information provided by (Responsible Party):
Centre for Addiction and Mental Health

Brief Summary:
This mixed methods study proposes a culturally adapted cognitive behavioural therapy (CA-CBT) model for an East Asian demographic in Canada. The client population of East Asian youth who have been diagnosed with anxiety and/or depression are the focus of the study. CBT has been proven as a very effective form of therapy, and when adapted can promote positive mental health outcomes for a growing and increasingly vulnerable population. Developing a culturally adapted version of CBT (CA-CBT) for this population adds a practical treatment that improves access to culturally relevant care.

Condition or disease Intervention/treatment Phase
Anxiety Depression Behavioral: Cognitive Behavioral Therapy Not Applicable

Detailed Description:
There is a major lack of culturally relevant mental health services for East Asian youth in Ontario and Canada. Beginning with a participatory/qualitative research approach, common themes amongst clients, caregivers, healthcare professionals, and community leaders, will divulge basic elements needed to develop a culturally adapted model of cognitive behavioural therapy. The information from the adapted model will be taught to participating psychologists who will deliver the therapy in a randomized control trial design, with feasibility testing of the intervention using a quantitative approach ensuing. Immediate guidelines will then be developed for use by therapists working with East Asian youth.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 36 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: East Asian youth diagnosed with Anxiety and/or depression will be randomly assigned to either the experimental group (receives the cultural adapted version of cognitive behavioral therapy) or the control group (non-culturally adapted cognitive behavioral therapy). It is a randomized control trial design.
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Improving Access to High Quality, Culturally Relevant Treatment for East Asian Canadian Youth in Ontario
Actual Study Start Date : January 4, 2019
Estimated Primary Completion Date : September 18, 2019
Estimated Study Completion Date : September 18, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Anxiety

Arm Intervention/treatment
Experimental: Culturally adapted Cognitive Behavioral therapy
The experimental group will receive the culturally adapted version of cognitive behavioral therapy.
Behavioral: Cognitive Behavioral Therapy
The intervention will be administered by therapists working at community agencies who are experienced at providing Cognitive Behavioral Therapy.

Active Comparator: Non-adapted Cognitive Behavioral therapy
The control group will receive the original (non-adapted) version of cognitive behavioral therapy.
Behavioral: Cognitive Behavioral Therapy
The intervention will be administered by therapists working at community agencies who are experienced at providing Cognitive Behavioral Therapy.




Primary Outcome Measures :
  1. Severity levels of depression and anxiety rated by the Hospital Anxiety and Depression Scale (HADS). [ Time Frame: 4 months. ]
    Severity levels of depression and anxiety will be rated pre- and post-intervention by the Hospital Anxiety and Depression Scale (HADS). The scale ranges from 0 to 21 for anxiety and 0 to 21 for depression. A score of 0 to 7 for depression and/or anxiety is considered a normal range. A score of 8 to 10 suggests the potential presence of depression and/or anxiety. A score of 11 or more suggests a likely presence of depression and/or anxiety.

  2. Severity levels of depression and anxiety rated by the Bradford Somatic Inventory (BSI). [ Time Frame: 4 months. ]
    Severity levels of depression and anxiety will be rated pre- and post-intervention by the Bradford Somatic Inventory (BSI). The Bradford Somatic Inventory uses "yes" or "no" questions relating to somatic symptoms of anxiety and/or depression. A "yes" response to a question equates to a somatic symptom linked to depression and/or anxiety. The maximum number of "yes" responses is 46 and the minimum is 0. A higher number of "yes" responses suggests a potential increase in the severity of depression and/or anxiety.


Secondary Outcome Measures :
  1. Satisfaction of the culturally adapted Cognitive Behavioral Therapy assessed using the Verona Satisfaction Scale. [ Time Frame: 4 months. ]
    Satisfaction will be measured using the Verona Satisfaction Scale. This scale measures patients satisfaction with health care services. The items are rated by 4 categories labelled: "strongly disagree", "disagree", "agree", and "strongly agree", on a scale of 1 to 4. A higher sub-scale/domain score indicates better satisfaction. All sub-scales are summed up to compute total/domain score. This scale will be used to identify the strengths and weaknesses of the therapy service and provide guidance for further development.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   12 Years to 21 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Self identification as East Asian origin
  • Between the ages of 12 to 21
  • Diagnosed as having depression and/or anxiety

Exclusion Criteria:

  • Have been affected by psychosis
  • Have been affected by serious addiction
  • Have been affected by cognitive impairment

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03711344


Contacts
Layout table for location contacts
Contact: Myra Levy 416-438-3697 ext 12243 mlevy@emys.on.ca
Contact: Sireesha Bobbili, MPH 416-535-8501 ext 36573 Sireesha.Bobbili@camh.ca

Locations
Layout table for location information
Canada, Ontario
East Metro Youth Services Recruiting
Scarborough, Ontario, Canada, M1H 3C3
Contact: Myra Levy    4164383697 ext 12243    mlevy@emys.on.ca   
Contact: Arlene GonashNelson       agonashnelson@emys.on.ca   
Principal Investigator: Farooq Naeem, PhD/MD         
Sponsors and Collaborators
Centre for Addiction and Mental Health
East Metro Youth Services
Hong Fook Mental Health Association
Ontario Centre of Excellence for Child and Youth Mental Health
Investigators
Layout table for investigator information
Principal Investigator: Farooq Naeem, M.D. Centre for Addiction and Mental Health
Study Director: Myra Levy, M.A. East Metro Youth Services
Layout table for additonal information
Responsible Party: Centre for Addiction and Mental Health
ClinicalTrials.gov Identifier: NCT03711344    
Other Study ID Numbers: innovation-1927
First Posted: October 18, 2018    Key Record Dates
Last Update Posted: February 1, 2019
Last Verified: January 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Centre for Addiction and Mental Health:
Cognitive Behavioral Therapy
Cultural Adaptation
East Asian Youth
Additional relevant MeSH terms:
Layout table for MeSH terms
Depression
Behavioral Symptoms